Home
>
US Stocks
>
Kezar Life Sciences Inc
Kezar Life Sciences Inc
KZR

Kezar Life Sciences Inc

$8.3525.38%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
8.65
Today Low/High
8.16 / 8.65
52 Week Low/High
$4.34 / $7.4
Market Cap
$272.29M

Company Details

Based in South San Francisco, Kezar Life Sciences is combining courage, conviction and cutting-edge science to develop breakthrough treatments for immune-mediated and oncologic disorders. The company is pioneering first-in-class, small-molecule therapies that harness master regulators of cellular function and inhibit multiple drivers of disease via a single target. KZR-616, a first-in-class selective immunoproteasome inhibitor, is being evaluated in severe and underserved autoimmune diseases. Additionally, KZR-261, the first clinical candidate for the treatment of cancer from the company's protein secretion program targeting the Sec61 translocon, is undergoing IND-enabling activities.
Organisation
Kezar Life Sciences Inc
Headquaters
South San Francisco, California, US
Employees
47
Industry
Health Technology
CEO
John Fowler

Discover more

Frequently Asked Questions

What is Kezar Life Sciences Inc share price today

Can Indians buy Kezar Life Sciences Inc shares?

How can I buy Kezar Life Sciences Inc shares from India?

Can Fractional shares of Kezar Life Sciences Inc be purchased?

What are the documents required to start investing in Kezar Life Sciences Inc stocks?

We are a SEBI registered investement advisor